SEC Form 4 · accession 0001645627-18-000072
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Nov 14, 2018
Accepted (ET)
Nov 20, 2018 · 3:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 14, 2018 | P | 1,000 | $0.0375 | A | 26,148,498 | D | |
| Common Stock | Nov 14, 2018 | P | 2,000 | $0.0368 | A | 26,150,498 | D | |
| Common Stock | Nov 15, 2018 | P | 1,000 | $0.0366 | A | 26,151,498 | D | |
| Common Stock | Nov 15, 2018 | P | 1,000 | $0.0346 | A | 26,152,498 | D | |
| Common Stock | Nov 15, 2018 | P | 2,000 | $0.0347 | A | 26,154,498 | D | |
| Common Stock | Nov 15, 2018 | P | 2,000 | $0.0346 | A | 26,156,498 | D | |
| Common Stock | Nov 16, 2018 | P | 2,000 | $0.0343 | A | 26,158,498 | D | |
| Common Stock | Nov 19, 2018 | P | 2,000 | $0.0315 | A | 26,160,498 | D | |
| Common Stock | Nov 19, 2018 | P | 1,000 | $0.03 | A | 26,161,498 | D |
Table II — derivative securities
No Table II lines on this filing.